| Impact of the doctor-patient relationship FE Chipidza, RS Wallwork, TA Stern The primary care companion for CNS disorders 17 (5), 27354, 2015 | 371 | 2015 |
| Use of frailty to predict survival in elderly patients with early stage non-small-cell lung cancer treated with stereotactic body radiation therapy I Franco, YH Chen, F Chipidza, V Agrawal, J Romano, E Baldini, A Chen, ... Journal of geriatric oncology 9 (2), 130-137, 2018 | 41 | 2018 |
| Evaluation and treatment of the angry patient F Chipidza, RS Wallwork, TN Adams, TA Stern The primary care companion for CNS disorders 18 (3), 26339, 2016 | 30 | 2016 |
| Prostate cancer‐specific mortality burden by risk group among men with localized disease: Implications for research and clinical trial priorities EC Dee, MD Nezolosky, FE Chipidza, MA Arega, SS Butler, ST Sha, ... The Prostate 80 (13), 1128-1133, 2020 | 23 | 2020 |
| Development and validation of a novel TP53 mutation signature that predicts risk of metastasis in primary prostate cancer FE Chipidza, M Alshalalfa, BA Mahal, RJ Karnes, Y Liu, E Davicioni, ... Clinical genitourinary cancer 19 (3), 246-254. e5, 2021 | 14 | 2021 |
| Genomic and clinical characterization of stromal infiltration markers in prostate cancer BA Mahal, M Alshalalfa, SG Zhao, H Beltran, WS Chen, F Chipidza, ... Cancer 126 (7), 1407-1412, 2020 | 14 | 2020 |
| Obstacles to the prescription and use of opioids RS Wallwork, FE Chipidza, TA Stern The primary care companion for CNS disorders 18 (1), 27047, 2016 | 13 | 2016 |
| Are staging computed tomography (CT) scans of the chest necessary in pancreatic adenocarcinoma? WT Mehtsun, FE Chipidza, C Fernández-del Castillo, K Hemingway, ... Annals of Surgical Oncology 25, 3936-3942, 2018 | 12 | 2018 |
| Breast cancer in Zimbabwe: patterns of care and correlates of adherence in a national referral hospital radiotherapy center cohort from 2014 to 2018 SNC Elmore, M Mushonga, HS Iyer, C Kanda, S Chibonda, F Chipidza, ... Cancer Medicine 10 (11), 3489-3498, 2021 | 10 | 2021 |
| Novel genomic signature predictive of response to immune checkpoint blockade: A pan-cancer analysis from project Genomics Evidence Neo-plasia Information Exchange (GENIE) N Swami, WL Hwang, JA Guo, H Hoffman, MC Abramowitz, Z Elbakouny, ... Cancer genetics 258, 61-68, 2021 | 4 | 2021 |
| Patterns of palliative radiotherapy utilization for patients with metastatic breast cancer in Harare, Zimbabwe M Mushonga, AM Nyakabau, N Ndlovu, HS Iyer, JR Bellon, C Kanda, ... JCO Global Oncology 7, 1212-1219, 2021 | 4 | 2021 |
| Accuracy of Pathologic Diagnosis in Patients With Lymphoma and Survival: A Prospective Analysis From Botswana FE Chipidza, MKA Kayembe, I Nkele, JA Efstathiou, BA Chabner, ... JCO Global Oncology 7, 1620-1632, 2021 | 3 | 2021 |
| Utilization and predictors of postmastectomy radiation receipt in an Oncology Center in Zimbabwe FE Chipidza, M Mushonga, C Kanda, S Chibonda, HS Iyer, MP Dykstra, ... Breast Cancer Research and Treatment 189 (3), 701-709, 2021 | 3 | 2021 |
| Association between treatment center experience and survival after diagnosis of stage I to III Merkel cell carcinoma treated with surgery with or without postoperative … FE Chipidza, M Thakuria, JD Schoenfeld, AW Silk, PJ Catalano, CH Yoon, ... Journal of the American Academy of Dermatology 84 (3), 875-877, 2021 | 3 | 2021 |
| Modified frailty index as a predictor of overall and other cause-specific survival in early-stage non-small cell lung cancer patients treated with stereotactic body radiation … I Franco, J Romano, F Chipidza, EH Baldini, AB Chen, YH Chen, ... International Journal of Radiation Oncology, Biology, Physics 96 (2), E449-E450, 2016 | 3 | 2016 |
| Stereotactic radiosurgery in patients with small cell lung cancer and 1-10 brain metastases: A multi-institutional, phase II, prospective clinical trial. A Aizer, WL Bi, PJ Catalano, F Chipidza, DA Haas-Kogan, L Hertan, ... Journal of Clinical Oncology 42 (16_suppl), 2020-2020, 2024 | 2 | 2024 |
| A comprehensive cancer center in the cloud powered by AI can reduce health disparities W Ngwa, A Pressley, VM Wilson, R Marlink, Y Quintana, F Chipidza, ... Nature medicine 30 (9), 2388-2389, 2024 | 1 | 2024 |
| Adjuvant and salvage radiotherapy after neoadjuvant therapy and radical prostatectomy for high‐risk localized prostate cancer P Ravi, L Kwak, W Devlies, W Xie, F Chipidza, X Yang, G Bubley, I Kaplan, ... The Prostate 84 (4), 342-348, 2024 | | 2024 |
| Distinct Profiles of DNA Repair Activity Define Favorable-risk Prostate Cancer Subtypes With Divergent Outcome N Swami, T Nguyen, I Ogobuiro, M Abramowitz, F Chipidza, E Davicioni, ... Clinical genitourinary cancer 21 (1), 76-83, 2023 | | 2023 |
| Effect of Treatment Center Experience on Survival after Diagnosis of Stage I-III Merkel Cell Carcinoma Treated with Surgery with or without Postoperative Radiation Therapy FE Chipidza, M Thakuria, JD Schoenfeld, AW Silk, PJ Catalano, C Yoon, ... International Journal of Radiation Oncology, Biology, Physics 108 (3), e10, 2020 | | 2020 |
